8results about How to "Timely treatment" patented technology

The utility model provides a vital sign monitoring stretcher, which relates to the technical field of stretchers and comprises a base plate, a connecting plate, a connecting plate, a connecting block, an isolation pad and an adjusting component. One group of first rotating rods are driven to rotate through a handle, so that a second rotating rod is driven to move, an old isolation pad above a base plate is conveniently rolled, a new isolation pad is moved to the position above the base plate, the disinfection and cleaning efficiency is improved, in an emergency, the isolation pad is rapidly replaced, the downtime of the stretcher is shortened, and the working efficiency of the stretcher is improved. The first rotating rod and the second rotating rod can be conveniently separated by detaching a first locking bolt, so that the second rotating rod can be conveniently taken down, a second locking bolt can be detached, a sleeve and the second rotating rod can be conveniently separated, and an isolation pad wound on the outer surface of the second rotating rod can be conveniently taken down. And frequent manual replacement of the isolation pad may occupy precious rescue time.

A pair of length-adjustable bipolar electric coagulation forceps relates to the technical field of medical instruments, and comprises a fixed seat and forceps rods, one end of the fixed seat is connected with a plug through a cable, the other end of the fixed seat is fixedly provided with a forceps handle, and the end part of the forceps handle is provided with a through hole; according to the length-adjustable bipolar electric coagulation forceps, the material is cheap, the processing cost is low, the inventory cost and the production management cost of manufacturers are greatly reduced, the length is convenient to adjust, and the length of the length-adjustable bipolar electric coagulation forceps is convenient to adjust. The operation attention of a doctor is not distracted, and the extra operation duration of a patient is prolonged, so that the patient is conveniently treated in time.

This invention discloses a blood culture detection system based on spectral reflectance technology, comprising: a culture container for culturing samples; a sensor for sensing the sample state and changing color according to changes in the sample state; a light signal acquisition component for projecting single-wavelength light onto the sensor and receiving the reflected light signal after reflection by the sensor; and a reading module for obtaining a reading result indicating whether the sample is infected based on the received reflected light signal; the light source is used to project at least two different colors of single-wavelength light onto the sensor. This invention also discloses an alarm method for the blood culture detection system based on spectral reflectance technology. The blood culture detection system and alarm method of this invention, based on spectral reflectance technology, improve the accuracy of positive rate readings by using different wavelength light sources for detection.

The invention relates to a balloon dilatation catheter capable of conveying intracavity treatment instruments, and relates to the technical field of medical equipment. Comprising a Luer taper, an inner tube, an outer tube, a balloon and a head end, one end of the inner tube is connected with the Luer taper, the other end of the inner tube is connected with the head end, one end of the outer tube is connected with the Luer taper, the other end of the outer tube is connected with the balloon, and the inner tube is sleeved with the outer tube and the balloon. The balloon is of a three-layer structure and sequentially comprises a sealing layer, a structural layer and a blood vessel contact layer from inside to outside. The device can be used for conveying and releasing thrombectomy stents and intracranial stents; the operation complexity of doctors is simplified, the process is simplified, the operation time is shortened, the safety is improved, and timely treatment of diseases is facilitated.

The invention provides EB (Epstein-Barr) virus nucleic acid detection primers, a probe and a kit, according to a target sequence of an EB virus gene, the sequences of the primers and the probe in an asymmetric primer ERA detection system are designed and screened, and the ratio of upstream and downstream primers and an amplification reaction system are optimized, so that the EB virus nucleic acid sequence can be specifically identified, and the EB virus nucleic acid detection kit has the advantages of high specificity and high sensitivity. Non-specific binding with other irrelevant nucleic acids is reduced, so that the detection specificity is improved; meanwhile, efficient amplification of EB virus nucleic acid is realized, and the EB virus nucleic acid can be accurately detected even under the condition that the content of the virus nucleic acid is extremely low, so that the detection sensitivity and the amplification efficiency are improved.

The application discloses a biomarker for predicting unexplained recurrent spontaneous abortion and application thereof, and belongs to the technical field of molecular diagnosis and molecular biology. By comparing serum detection of 45 unexplained recurrent spontaneous abortion patients, it is found that the expression level of miR-142-3p in the serum of the unexplained recurrent spontaneous abortion patients is obviously higher than that of normal pregnant women. Compared with the normal pregnant women, the peripheral blood CD4 + CD25 + Treg cell level of the unexplained recurrent spontaneous abortion patients is significantly increased. By detecting the expression level of miR-142-3p, the unexplained recurrent spontaneous abortion patients can be pre-judged, so that the miR-142-3p can be used as an important index for clinically diagnosing and evaluating unexplained recurrent spontaneous abortion.

The present application relates to the technical field of molecular detection and diagnosis, and particularly relates to a tetrahedral probe, a preparation method thereof and application of the tetrahedral probe in detection of apurinic / apyrimidinic endonuclease 1 (APE1). The DNA tetrahedral probe is formed by self-assembly of a frame DNA chain, a triple helix complex and a hairpin H chain. The frame DNA chains interact to form a stable tetrahedral skeleton; when APE1 exists in a sample, it can specifically recognize and cut apurinic / apyrimidinic sites on the triple helix complex and the hairpin H chain, trigger a cascade reaction and realize signal amplification; nucleic acid drugs in the probe are released with the cutting, and thus the synergy of detection and treatment is realized. The technical solution can solve the technical problem of unsatisfactory sensitivity and accuracy of in vitro detection of APE1 enzyme in the prior art, has low detection limit and wide linear range. The technical solution has important clinical application value and scientific research significance, and is expected to promote the development of non-small cell lung cancer diagnosis and treatment technology.

This invention relates to the field of machine learning scheduling technology, specifically to an intelligent triage and scheduling system based on patient data streams. The system includes a vital sign acquisition module, a deterioration distribution module, an equipment triggering module, an access control addressing module, and a triage and scheduling module. In this invention, multidimensional patient monitoring data is extracted and compared with a safety baseline within a continuous observation window. Deviations are continuously accumulated and cross-aggregated to construct an objective quantitative baseline characterizing the degree of deterioration in the patient's overall condition. When the deterioration score exceeds the takeover threshold, the system skips the software queuing process to locate an available physical emergency space. The underlying network switches electronic access control and emergency equipment relays to the activation level, forcibly opening the physical emergency channel. This eliminates the time loss caused by critically ill patients waiting for room cleaning and equipment activation, achieving an instantaneous transition from critical vital sign data to hardware-level scheduling and control commands, ensuring that critically ill patients receive timely and effective treatment.